Gullo’s syndrome – what do we know?

Gullo’s syndrome – what do we know?

Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. G...

Full description

Bibliographic Details
Main Authors: Anna Rycyk, Paulina Furtak, Agnieszka Mądro, Beata Kasztelan-Szczerbińska, Halina Cichoż-Lach
Format: Article
Language:English
Published: Termedia Publishing House 2020-11-01
Series:Gastroenterology Review
Subjects:
gullo's syndrome
benign pancreatic hyperenzymemia.
Online Access:https://www.termedia.pl/Gullo-s-syndrome-what-do-we-know-,41,42497,1,1.html
id doaj-6b1eb5976c4f4915aacb6e335db29d74
record_format Article
spelling doaj-6b1eb5976c4f4915aacb6e335db29d742021-10-06T08:13:10ZengTermedia Publishing HouseGastroenterology Review1895-57701897-43172020-11-0116318118310.5114/pg.2020.10113342497Gullo’s syndrome – what do we know?Anna RycykPaulina FurtakAgnieszka MądroBeata Kasztelan-SzczerbińskaHalina Cichoż-LachBenign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. Gullo’s syndrome is a diagnosis of exclusion, and clinicians should be aware of various other conditions which can cause elevation of pancreatic enzymes. However, the diagnostic pathway should be done with the right accuracy to avoid unnecessary examinations.https://www.termedia.pl/Gullo-s-syndrome-what-do-we-know-,41,42497,1,1.htmlgullo's syndrome benign pancreatic hyperenzymemia.
collection DOAJ
language English
format Article
sources DOAJ
author Anna Rycyk
Paulina Furtak
Agnieszka Mądro
Beata Kasztelan-Szczerbińska
Halina Cichoż-Lach
spellingShingle Anna Rycyk
Paulina Furtak
Agnieszka Mądro
Beata Kasztelan-Szczerbińska
Halina Cichoż-Lach
Gullo’s syndrome – what do we know?
Gastroenterology Review
gullo's syndrome
benign pancreatic hyperenzymemia.
author_facet Anna Rycyk
Paulina Furtak
Agnieszka Mądro
Beata Kasztelan-Szczerbińska
Halina Cichoż-Lach
author_sort Anna Rycyk
title Gullo’s syndrome – what do we know?
title_short Gullo’s syndrome – what do we know?
title_full Gullo’s syndrome – what do we know?
title_fullStr Gullo’s syndrome – what do we know?
title_full_unstemmed Gullo’s syndrome – what do we know?
title_sort gullo’s syndrome – what do we know?
publisher Termedia Publishing House
series Gastroenterology Review
issn 1895-5770
1897-4317
publishDate 2020-11-01
description Benign pancreatic hyperenzymemia (Gullo’s syndrome) is characterized by a more than threefold increase of the serum pancreatic enzymes lipase and amylase activity in the absence of any pancreatic disease. Recently, there is an increase in describing cases of Gullo’s syndrome in medical literature. Gullo’s syndrome is a diagnosis of exclusion, and clinicians should be aware of various other conditions which can cause elevation of pancreatic enzymes. However, the diagnostic pathway should be done with the right accuracy to avoid unnecessary examinations.
topic gullo's syndrome
benign pancreatic hyperenzymemia.
url https://www.termedia.pl/Gullo-s-syndrome-what-do-we-know-,41,42497,1,1.html
work_keys_str_mv AT annarycyk gullossyndromewhatdoweknow
AT paulinafurtak gullossyndromewhatdoweknow
AT agnieszkamadro gullossyndromewhatdoweknow
AT beatakasztelanszczerbinska gullossyndromewhatdoweknow
AT halinacichozlach gullossyndromewhatdoweknow
_version_ 1716841074368970752

Similar Items